|
NCL
NCL
NCL - New Clicks Holdings - Acquisition of stake in Direct Medicines
New Clicks Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 1996/000645/06)
JSE share code: NCL
ISIN: ZAE000014585
("New Clicks")
NEW CLICKS ACQUIRES 60% STAKE IN DIRECT MEDICINES
New Clicks has acquired a 60% stake in leading courier pharmacy business, Direct
Medicines, for a cash payment of R13.2 million.
David Kneale, group chief executive of New Clicks, said the acquisition will
enable Clicks to broaden its coverage in the retail pharmacy market and
accelerate its national pharmacy presence.
The transaction is expected to be effective from 1 September 2008 and is subject
to regulatory approvals. New Clicks has the option to acquire the remaining 40%
of the business after three years.
"Subsequent to regulatory approval the business will be rebranded as Clicks
Direct Medicines and will complement the Clicks in-store pharmacy network.
Courier pharmacy customers will now also have the option to collect chronic
medication at Clicks pharmacy stores across the country. All medication for
Clicks Direct Medicines will in future be procured through UPD, the wholesale
pharmaceutical distributor in the New Clicks stable," said Kneale.
"Courier pharmacy is a growth market in South Africa, with an estimated 10% of
all chronic medication being dispensed through courier pharmacies last year. We
believe courier pharmacy is cost effective and supports Government`s objective
of making medicine more affordable and accessible to all South Africans," said
Kneale.
Direct Medicines was established in Johannesburg in 1994 as part of Afrox
Healthcare (later Life Healthcare). Following a management buyout from Life
Healthcare in 2005 the business has been independently owned and managed.
Post the New Clicks acquisition, the remaining shares in Direct Medicines will
be held by empowerment group Vuwa Healthcare (26%) and management (14%).
Direct Medicines has an annual turnover of R225 million and dispenses over
650 000 prescriptions annually across South Africa, Lesotho and Swaziland.
Direct Medicines has relationships with over 100 medical schemes. Further
information on the business is available at www.directmedicines.co.za.
Cape Town
11 August 2008
For further information contact
Tier 1 Investor Relations
Tel +27 (21) 702-3102
Investment Bank and Sponsor
Investec Bank Limited
Date: 11/08/2008 14:35:03 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
| Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information. | |||||||||||||
| Other Profile Group sites: FundsData Online (unit trust data) | Profile Group corporate site | |||||||||||||
| [ Terms of Use | Privacy Policy | PAIA manual | FAQs/Help | Site Map | © Copyright Reserved 2026 ] | |||||||||||||
|
|||||||||||||
